Home
AbbVie ABBV paid Brownstein Hyatt Farber Schreck $60K for lobbying in Q4 2022 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2022
- Stock
- AbbVie ABBV
- Client
- Abbvie
- Reported
- 23/01/18
$1.4M on lobbying in 2022
What else happened in AbbVie around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Abbvie's other lobbying reports
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$50K
$50K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$1.2M
$1.2M
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$60K
$60K
Reported 07/20
for Q2
- Abbvie
LobbyingAbbVie
LobbyingAbbVie
ABBV
$30K
$30K
Reported 07/20
for Q2